Post by NOUL Co., Ltd.

Is it time to rethink the manual standard in cervical cytology? As more countries across Europe transition to HPV primary screening, the demand for cytology triage continues to grow. At the same time, many healthcare systems are facing a shortage of experienced cytologists, making it increasingly difficult to maintain high-quality cervical cytology review while managing growing workloads, fragmented systems, and limited specialist resources. miLab™ CER is designed to support a more integrated and digital approach to cervical cytology. By combining automated Pap staining, digital imaging, and AI-assisted analysis in a single compact platform, miLab™ CER helps simplify cervical cytology workflows across laboratories and mobile screening units. Its streamlined workflow can help reduce infrastructure and logistics barriers, supporting broader access to cervical cancer screening. miLab™ CER supports: 🔬 High-quality, automated cervical cytology workflows 🧠 AI-assisted review support for trained professionals 🌍 Flexible deployment with remote digital review capability ♻️ Reduced infrastructure, storage, logistics, and water-use requirements 🎗️ Broader access to cervical cancer screening for women Improving cervical cancer screening is not only about technology—it is about creating practical and scalable workflows that help more women access reliable screening services. At NOUL Co., Ltd., we are committed to supporting healthcare providers as they improve efficiency, expand access, and contribute to broader access to cervical cancer screening for women. Interested in learning how miLab™ CER can support your cervical cancer screening program? We'd be happy to start the conversation. 📩 contact: [email protected] #CervicalCancerScreening #CervicalCancer #DigitalCytology #AIinHealthcare #WomensHealth #miLabCER